就医网
医学版
English
党建网
contacts|FAQ
Location: Home > Main Subjects Main Subjects
Oriental Organ Transplant Center/ Tianjin Organ Transplant Institute
2013-07-08 10:56:45

As one of Tianjin key disciplines and equipped with 200 beds, Organ Transplant Center is the one and only unit in China which can meanwhile operate liver transplantation, kidney transplantation, pancreas transplantation, small bowel transplantation, heart transplantation and lung transplantation. The center is staffed with professional personnel, of which 26 people hold the deputy high titles and above, and 30% people have achieved master's degree and above. Up to the end of May 2009, it has completed a total of 3330 cases of liver transplantation, 2357 cases of renal transplant, and 31 cases of simultaneous pancreas-kidney transplantation. The quantity of liver transplants has been listed top one for a succession of 10 years since 1998. Especially in 2005 and 2006, the world record was broken in that of liver transportation. The survival rates of liver transplantation after 1 year, 3 year and 5-years are respectively 83.1%, 72.9% and 69.3%. Oriental Organ Transplant Center has been the largest organ transplant center in Asia, meanwhile of great influence in the world. Beijing Union Medical College Hospital, Beijing Chaoyang Hospital, Beijing University People's Hospital, and other 50 hospitals in over 20 cities are under its guidance to carry out their first successful liver transplantations, and over 200 doctors on organ transplant receive training from the hospital.

 

 

"Lamivudine + hepatitis B immunoglobulin (HBIG)" is first put into use domestically in the hospital to prevent hepatitis B recurrence after liver transplantation, which has found its clinical application in most of the liver transplant centers, including "hepatitis B liver cirrhosis at the treatment end-stage of liver transplant", and has been awarded the second prize for Tianjin scientific and technological progress. In accordance with the source features of donor livers, the joint cut operation of liver and kidney has been advanced for the correct and effective perfusion and preservation, and the infusion line with filter membrane has been developed and mass produced in the use of the majority of transplant centers across the country, and applied for a new type of technology patent Systematical research has been done on the causes, prevention, and treatment of biliary stricture after liver transplantation for the first time in China, and classification methods and a comprehensive treatment strategy for biliary stricture have been proposed, according to the different treatment, winning the third prize for Tianjin scientific and technological progress. The successful implementation of a living-related liver transplantation currently is the top one in the accumulative number in China. More than 200 cases of the proposed distribution of hepatic vein and donor liver vein reconstruction program have been implemented in clinical practice, confirming the program not only for ensuring the safety of the donor but for the clinical effects of the recipient The first domestic case of a successful completion of simultaneous integrated liver and kidney transplantation, the world's first contemporary domino donor liver plus the living left liver dual-liver transplantation, split liver transplantation, pediatric liver transplantation, "combination of liver transplantation chain" of multiple donors and recipients will push the liver transplantation techniques to the peak.